{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06373146",
            "orgStudyIdInfo": {
                "id": "18750"
            },
            "secondaryIdInfos": [
                {
                    "id": "I8F-MC-GPIV",
                    "type": "OTHER",
                    "domain": "Eli Lilly and Company"
                }
            ],
            "organization": {
                "fullName": "Eli Lilly and Company",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity",
            "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of Once-Weekly Tirzepatide Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "a-study-of-tirzepatide-plus-mibavademab-compared-with-tirzepatide-alone-in-adult-participants-with-obesity"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-16",
            "studyFirstSubmitQcDate": "2024-04-16",
            "studyFirstPostDateStruct": {
                "date": "2024-04-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Eli Lilly and Company",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Regeneron Pharmaceuticals",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main purpose of this study is to determine if combining tirzepatide with the mibavademab will result in more weight loss in adult participants than tirzepatide alone. The study will last about 72 weeks and may include up to 19 visits."
        },
        "conditionsModule": {
            "conditions": [
                "Obesity"
            ],
            "keywords": [
                "Glucagon-like peptide-1 (GLP-1)",
                "Leptin",
                "Incretin",
                "Weight maintenance"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 360,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Tirzepatide (TZP) + Mibavademab (MIBA) [Group A]",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive TZP subcutaneously (SC) and MIBA for 24 weeks. Participants in Group A will be randomized (Randomization 2) to groups C and D at week 24.",
                    "interventionNames": [
                        "Drug: Tirzepatide",
                        "Drug: Mibavademab"
                    ]
                },
                {
                    "label": "TZP + Mibavademab-placebo (MIBA-PBO) [Group B]",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive TZP SC and MIBA-PBO SC for 24 weeks. Participants in Group B will be randomized (Randomization 2) to Groups E, F, G, and H at week 24.",
                    "interventionNames": [
                        "Drug: Tirzepatide",
                        "Drug: Mibavademab-Placebo"
                    ]
                },
                {
                    "label": "TZP + MIBA then Tirzepatide-placebo (TZP-PBO) + MIBA [Group C]",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive TZP SC and MIBA SC for 24 weeks followed by TZP-PBO SC and MIBA SC for 24 weeks.",
                    "interventionNames": [
                        "Drug: Tirzepatide",
                        "Drug: Mibavademab",
                        "Drug: Tirzepatide-Placebo"
                    ]
                },
                {
                    "label": "TZP + MIBA [Group D]",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive TZP SC + MIBA-PBO SC for 48 weeks.",
                    "interventionNames": [
                        "Drug: Tirzepatide",
                        "Drug: Mibavademab"
                    ]
                },
                {
                    "label": "TZP + MIBA-PBO [Group E]",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive TZP SC + MIBA-PBO SC for 48 weeks.",
                    "interventionNames": [
                        "Drug: Tirzepatide",
                        "Drug: Mibavademab-Placebo"
                    ]
                },
                {
                    "label": "TZP + MIBA-PBO then TZP-PBO + MIBA [Group F]",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive TZP SC + MIBA-PBO SC for 24 weeks followed by TZP-PBO SC + MIBA SC for 24 weeks.",
                    "interventionNames": [
                        "Drug: Tirzepatide",
                        "Drug: Mibavademab",
                        "Drug: Tirzepatide-Placebo",
                        "Drug: Mibavademab-Placebo"
                    ]
                },
                {
                    "label": "TZP + MIBA-PBO then TZP + MIBA [Group G]",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive TZP SC + MIBA-PBO SC for 24 weeks followed by TZP SC + MIBA SC for 24 weeks.",
                    "interventionNames": [
                        "Drug: Tirzepatide",
                        "Drug: Mibavademab",
                        "Drug: Mibavademab-Placebo"
                    ]
                },
                {
                    "label": "TZP + MIBA-PBO then TZP-PBO + MIBA-PBO [Group H]",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive TZP SC + MIBA-PBO SC for 24 weeks followed by TZP-PBO SC + MIBA-PBO SC for 24 weeks.",
                    "interventionNames": [
                        "Drug: Tirzepatide",
                        "Drug: Tirzepatide-Placebo",
                        "Drug: Mibavademab-Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Tirzepatide",
                    "description": "Administered SC",
                    "armGroupLabels": [
                        "TZP + MIBA [Group D]",
                        "TZP + MIBA then Tirzepatide-placebo (TZP-PBO) + MIBA [Group C]",
                        "TZP + MIBA-PBO [Group E]",
                        "TZP + MIBA-PBO then TZP + MIBA [Group G]",
                        "TZP + MIBA-PBO then TZP-PBO + MIBA [Group F]",
                        "TZP + MIBA-PBO then TZP-PBO + MIBA-PBO [Group H]",
                        "TZP + Mibavademab-placebo (MIBA-PBO) [Group B]",
                        "Tirzepatide (TZP) + Mibavademab (MIBA) [Group A]"
                    ],
                    "otherNames": [
                        "LY3298176"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Mibavademab",
                    "description": "Administered SC",
                    "armGroupLabels": [
                        "TZP + MIBA [Group D]",
                        "TZP + MIBA then Tirzepatide-placebo (TZP-PBO) + MIBA [Group C]",
                        "TZP + MIBA-PBO then TZP + MIBA [Group G]",
                        "TZP + MIBA-PBO then TZP-PBO + MIBA [Group F]",
                        "Tirzepatide (TZP) + Mibavademab (MIBA) [Group A]"
                    ],
                    "otherNames": [
                        "REGN4461"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Tirzepatide-Placebo",
                    "description": "Administered SC",
                    "armGroupLabels": [
                        "TZP + MIBA then Tirzepatide-placebo (TZP-PBO) + MIBA [Group C]",
                        "TZP + MIBA-PBO then TZP-PBO + MIBA [Group F]",
                        "TZP + MIBA-PBO then TZP-PBO + MIBA-PBO [Group H]"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Mibavademab-Placebo",
                    "description": "Administered SC",
                    "armGroupLabels": [
                        "TZP + MIBA-PBO [Group E]",
                        "TZP + MIBA-PBO then TZP + MIBA [Group G]",
                        "TZP + MIBA-PBO then TZP-PBO + MIBA [Group F]",
                        "TZP + MIBA-PBO then TZP-PBO + MIBA-PBO [Group H]",
                        "TZP + Mibavademab-placebo (MIBA-PBO) [Group B]"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Mean Percent Change from Baseline in Body Weight",
                    "timeFrame": "Baseline, Week 48"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean Change from Baseline for Percent Change and Absolute Change in Body Weight (kg)",
                    "timeFrame": "Baseline, Week 24"
                },
                {
                    "measure": "Mean Absolute Change from Baseline for Body Weight (kg)",
                    "timeFrame": "Baseline, Week 48"
                },
                {
                    "measure": "Percentage of Participants Who Achieve \u22655% Body Weight Reduction",
                    "timeFrame": "Baseline to Week 48"
                },
                {
                    "measure": "Percentage of Participants Who Achieve \u226510% Body Weight Reduction",
                    "timeFrame": "Baseline to Week 48"
                },
                {
                    "measure": "Percentage of Participants Who Achieve \u226515% Body Weight Reduction",
                    "timeFrame": "Baseline to Week 48"
                },
                {
                    "measure": "Percentage of Participants Who Achieve \u226520 Body Weight Reduction",
                    "timeFrame": "Baseline to Week 48"
                },
                {
                    "measure": "Mean Percent Change from Randomization 2 for Body Weight",
                    "timeFrame": "Week 24, Week 48"
                },
                {
                    "measure": "Mean Change from Randomization 2 for Body Weight (kg)",
                    "timeFrame": "Week 24, Week 48"
                },
                {
                    "measure": "Mean Absolute Change from Randomization 2 for Body Weight (kg)",
                    "timeFrame": "Week 24, Week 48"
                },
                {
                    "measure": "Change from Baseline to Week 24 in CoEQ Scores",
                    "timeFrame": "Baseline, Week 24"
                },
                {
                    "measure": "Change from Baseline to Week 24 in CoEQ Scores",
                    "timeFrame": "Baseline, Week 48"
                },
                {
                    "measure": "Change from Baseline in FCQ-T-r Scores",
                    "timeFrame": "Baseline, Week 24"
                },
                {
                    "measure": "Change from Baseline in FCQ-T-r Scores",
                    "timeFrame": "Baseline, Week 48"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Have a body mass index (BMI) of \u226530 kilogram/square meter (kg/m2) and \u226440 kg/m2\n* Willing to learn how to self-inject study intervention (visually impaired persons who are not able to perform the injections must have the assistance of a sighted individual trained to inject the study intervention; persons with physical limitations who are not able to perform the injections must have the assistance of an individual trained to inject the study intervention)\n* Male or female contraceptive use by participant should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.\n\nExclusion Criteria:\n\n* Have a history of diabetes mellitus, including Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM), history of ketoacidosis, or hyperosmolar state/coma\n* Have a self-reported change (increase or decrease) in body weight \\>5 kilogram (kg) within 3 months prior to screening\n* Have a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia (MEN) syndrome type 2\n* Have acute or chronic hepatitis\n* Have a history of an active or untreated malignancy or are in remission from a clinically significant malignancy for less than 5 years",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or",
                    "role": "CONTACT",
                    "phone": "1-317-615-4559",
                    "email": "ClinicalTrials.gov@lilly.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)",
                    "affiliation": "Eli Lilly and Company",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Velocity Clinical Research, Gardena",
                    "status": "RECRUITING",
                    "city": "Gardena",
                    "state": "California",
                    "zip": "90247",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "424-551-7316"
                        },
                        {
                            "name": "Mark Leibowitz",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.88835,
                        "lon": -118.30896
                    }
                },
                {
                    "facility": "Irvine Clinical Research",
                    "status": "RECRUITING",
                    "city": "Irvine",
                    "state": "California",
                    "zip": "92614",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "949-753-1663"
                        },
                        {
                            "name": "Elly Lee",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.66946,
                        "lon": -117.82311
                    }
                },
                {
                    "facility": "National Research Institute - Wilshire",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90057",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "213-483-1800"
                        },
                        {
                            "name": "David Guzman",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Velocity Clinical Research, North Hollywood",
                    "status": "RECRUITING",
                    "city": "North Hollywood",
                    "state": "California",
                    "zip": "91606",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "208-377-8653"
                        },
                        {
                            "name": "Mark Turner",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.17223,
                        "lon": -118.37897
                    }
                },
                {
                    "facility": "Velocity Clinical Research, Panorama City",
                    "status": "RECRUITING",
                    "city": "Panorama City",
                    "state": "California",
                    "zip": "91402",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "818-616-8245"
                        },
                        {
                            "name": "Maricor Grio",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.22473,
                        "lon": -118.44981
                    }
                },
                {
                    "facility": "Velocity Clinical Research, Santa Ana",
                    "status": "RECRUITING",
                    "city": "Santa Ana",
                    "state": "California",
                    "zip": "92704",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "714-599-8711"
                        },
                        {
                            "name": "Julie Vu",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.74557,
                        "lon": -117.86783
                    }
                },
                {
                    "facility": "Diablo Clinical Research, Inc.",
                    "status": "RECRUITING",
                    "city": "Walnut Creek",
                    "state": "California",
                    "zip": "94598",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "925-930-7267"
                        },
                        {
                            "name": "Bonnie Kimmel",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.90631,
                        "lon": -122.06496
                    }
                },
                {
                    "facility": "Solaris Clinical Research",
                    "status": "RECRUITING",
                    "city": "Meridian",
                    "state": "Idaho",
                    "zip": "83646",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "208-288-0123"
                        },
                        {
                            "name": "David Butuk",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.61211,
                        "lon": -116.39151
                    }
                },
                {
                    "facility": "Tandem Clinical Research",
                    "status": "RECRUITING",
                    "city": "Marrero",
                    "state": "Louisiana",
                    "zip": "70072",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "504-934-8424"
                        },
                        {
                            "name": "Adil Fatakia",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.89937,
                        "lon": -90.10035
                    }
                },
                {
                    "facility": "Velocity Clinical Research - New Orleans",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70119",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "985-273-0855"
                        },
                        {
                            "name": "Scott Striplin",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                },
                {
                    "facility": "CenExel-HRI",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "state": "New Jersey",
                    "zip": "08009",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "856-753-7335"
                        },
                        {
                            "name": "Michael Hassman",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.79123,
                        "lon": -74.92905
                    }
                },
                {
                    "facility": "Lillestol Research",
                    "status": "RECRUITING",
                    "city": "Fargo",
                    "state": "North Dakota",
                    "zip": "58104",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "701-232-7705"
                        },
                        {
                            "name": "Michael Lillestol",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.87719,
                        "lon": -96.7898
                    }
                },
                {
                    "facility": "CTI-CRC",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45212",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "513-721-3868"
                        },
                        {
                            "name": "James Maynard",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "South Texas Clinical Research",
                    "status": "RECRUITING",
                    "city": "Corpus Christi",
                    "state": "Texas",
                    "zip": "78404",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "361-288-4668"
                        },
                        {
                            "name": "Lloyd Stegemann",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.80058,
                        "lon": -97.39638
                    }
                },
                {
                    "facility": "Dallas Diabetes Research Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75230",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "682-348-1169"
                        },
                        {
                            "name": "Julio Rosenstock",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Juno Research",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77040",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "713-779-5494"
                        },
                        {
                            "name": "Damaris Vega",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Northwest Clinical Research Center",
                    "status": "RECRUITING",
                    "city": "Bellevue",
                    "state": "Washington",
                    "zip": "98007",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "425-453-0404"
                        },
                        {
                            "name": "Nazia Rahman",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.61038,
                        "lon": -122.20068
                    }
                },
                {
                    "facility": "Centro de Investigacion en Artritis y Osteoporosis SC",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Mexicali",
                    "state": "Baja California",
                    "zip": "21200",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "52 686 5534121"
                        },
                        {
                            "name": "Francisco Fidencio Cons Molina",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.62781,
                        "lon": -115.45446
                    }
                },
                {
                    "facility": "Cl\u00ednicos Asociados BOCM",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Mexico City",
                    "state": "Distrito Federal",
                    "zip": "03300",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "name": "Israel Olvera-Alvarez",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 19.42847,
                        "lon": -99.12766
                    }
                },
                {
                    "facility": "Centro de Investigaci\u00f3n Cl\u00ednica y Medicina Traslacional (CIMeT)",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Guadalajara",
                    "state": "Jalisco",
                    "zip": "44340",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "523310482459"
                        },
                        {
                            "name": "Luis Rom\u00e1n Pintos",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 20.66682,
                        "lon": -103.39182
                    }
                },
                {
                    "facility": "Unidad biomedica avanzada monterrey",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Monterrey",
                    "state": "Nuevo Le\u00f3n",
                    "zip": "64460",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "8113578896"
                        },
                        {
                            "name": "Raymundo Garcia Reza",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.67507,
                        "lon": -100.31847
                    }
                },
                {
                    "facility": "Hospital Universitario \"Dr. Jose Eleuterio Gonzalez\"",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Monterrey",
                    "state": "Nuevo Le\u00f3n",
                    "zip": "66460",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "528183483220"
                        },
                        {
                            "name": "Jose Gerardo Gonzalez Gonzalez",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.67507,
                        "lon": -100.31847
                    }
                },
                {
                    "facility": "Medical Care and Research SA de CV",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Merida",
                    "state": "Yucat\u00e1n",
                    "zip": "97070",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "9999203879"
                        },
                        {
                            "name": "Carlos Medina",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 20.97537,
                        "lon": -89.61696
                    }
                },
                {
                    "facility": "Investigacion En Salud Y Metabolismo S.C / Nutricion Clinica / Unidad de Base de Datos",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Chihuahua",
                    "zip": "31110",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "526144398618"
                        },
                        {
                            "name": "Luis Nevarez",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.63528,
                        "lon": -106.08889
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity",
                    "url": "https://trials.lilly.com/en-US/trial/477977"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ],
            "timeFrame": "Data are available 6 months after the primary publication and approval of the indication studied in the US and European Union (EU), whichever is later. Data will be indefinitely available for requesting.",
            "accessCriteria": "A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.",
            "url": "http://vivli.org/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009765",
                    "term": "Obesity"
                }
            ],
            "ancestors": [
                {
                    "id": "D000050177",
                    "term": "Overweight"
                },
                {
                    "id": "D000044343",
                    "term": "Overnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                },
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "asFound": "Obesity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "relevance": "LOW"
                },
                {
                    "id": "M25307",
                    "name": "Overnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000629749",
                    "term": "Tirzepatide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000054795",
                    "term": "Incretins"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9043",
                    "name": "Glucagon",
                    "relevance": "LOW"
                },
                {
                    "id": "M26997",
                    "name": "Glucagon-Like Peptide 1",
                    "relevance": "LOW"
                },
                {
                    "id": "M204206",
                    "name": "Tirzepatide",
                    "asFound": "DISKUS",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27905",
                    "name": "Incretins",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}